Missouri Trust & Investment Company’s iShares Biotechnology ETF IBB Stock Holding History

Missouri Trust & Investment Company’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-80	Closed	-$13.5K	–	246
2026 Q1	$13.5K	Buy	+80	New	+$13.7K	﹤0.01%	316
2024 Q1	–	Sell	-100	Closed	-$13.6K	–	426
2023 Q4	$13.6K	Sell	100 -90	-47%	-$11K	0.01%	277
2023 Q3	$23.2K	Hold	190	–	–	0.01%	246
2023 Q2	$24.1K	Hold	190	–	–	0.01%	254
2023 Q1	$24.5K	Hold	190	–	–	0.02%	213
2022 Q4	$25K	Sell	190 -360	-65%	-$46.5K	0.02%	207
2022 Q3	$64K	Hold	550	–	–	0.04%	152
2022 Q2	$65K	Hold	550	–	–	0.04%	152
2022 Q1	$72K	Hold	550	–	–	0.04%	162
2021 Q4	$84K	Buy	+550	New	+$85.2K	0.05%	153

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Missouri Trust & Investment Company's IBB Position: Q2 2026 in Review

Missouri Trust & Investment Company sold out of iShares Biotechnology ETF (IBB) in Q2 2026, closing a stake of 80 shares — an estimated $13.5K sold.

Missouri Trust & Investment Company first reported a position in IBB in Q4 2021 and held it in 10 quarters. The position peaked at $84K in Q4 2021. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

Missouri Trust & Investment Company reported no remaining iShares Biotechnology ETF position as of Q2 2026 after selling out during the quarter.
Missouri Trust & Investment Company sold 80 iShares Biotechnology ETF shares in Q2 2026, an estimated $13.5K.
Missouri Trust & Investment Company first reported a position in iShares Biotechnology ETF in Q4 2021 and held it in 10 quarters.
Missouri Trust & Investment Company's iShares Biotechnology ETF position peaked at $84K in Q4 2021.
954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Missouri Trust & Investment Company's 13F filing for Q2 2026, filed 13 Aug 2026.